CIK 0001054102 · Non-accelerated filer<br>Smaller reporting company
INTERPACE BIOSCIENCES, INC.
Sign in to watch- Ticker
- IDXG
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222919486
- Phone
- 412-224-6100
- Business address
- WATERVIEW PLAZA, SUITE 310, 2001 ROUTE 46, PARSIPPANY, NJ, 07054
- Former names
- Interpace Diagnostics Group, Inc., PDI INC, PROFESSIONAL DETAILING INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-11 | Ampersand 2018 Limited Partnership 10% owner | Returned to the company · Series B Convertible Preferred Stock | +28,000 | 0 | ||
| 2024-10-11 | Ampersand 2018 Limited Partnership 10% owner | Grant or award · Series C Convertible Preferred Stock | +28,000 | 28,000 | ||
| 2024-07-27 | McCarthy Christopher Chief Financial Officer | Option exercise | +15,112 | 45,680 | ||
| 2024-02-01 | McCarthy Christopher Chief Financial Officer | Option exercise | +6,045 | 30,568 | ||
| 2024-02-01 | McCarthy Christopher Chief Financial Officer | Grant or award | +10,000 | 45,644 | ||
| 2024-01-31 | McCarthy Christopher Chief Financial Officer | Option exercise | +7,556 | 24,523 | ||
| 2023-12-01 | McCarthy Christopher Chief Financial Officer | Option exercise | +1,095 | 16,967 | ||
| 2023-07-31 | McCarthy Christopher Chief Financial Officer | Option exercise | +7,556 | 15,872 | ||
| 2023-07-31 | McCarthy Christopher Chief Financial Officer | Grant or award | +25,000 | 35,644 | ||
| 2022-02-01 | AGGARWAL VIJAY Director | Grant or award · Stock Option (right to buy) | +28,000 | 28,000 | ||
| 2021-05-21 | Burnell Thomas W. President & CEO | Purchase | +10,855 | $8.68 | $94K | 10,855 |
| 2021-03-10 | Freeburg Thomas John Chief Financial Officer | Grant or award | +50,000 | 52,000 | ||
| 2021-03-10 | Freeburg Thomas John Chief Financial Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2021-03-01 | Kamin Peter 10% owner | Purchase | +16,360 | $3.08 | $50K | 270,108 |
| 2021-03-01 | Kamin Peter 10% owner | Purchase | +14,726 | $3.08 | $45K | 234,805 |
| 2021-03-01 | Kamin Peter 10% owner | Purchase | +8,252 | $3.08 | $25K | 133,186 |
| 2021-03-01 | Kamin Peter 10% owner | Purchase | +2,862 | $3.08 | $9K | 44,670 |
| 2021-02-26 | Kamin Peter 10% owner | Purchase | +14,946 | $3.17 | $47K | 253,748 |
| 2021-02-26 | Kamin Peter 10% owner | Purchase | +14,874 | $3.17 | $47K | 220,079 |
| 2021-02-26 | Kamin Peter 10% owner | Purchase | +8,333 | $3.17 | $26K | 124,934 |
Page 2 of 8 · 158 trades